WALTHAM, Mass., November 25, 2020 – Axial Therapeutics Inc., a biotechnology company dedicated to building a unique class of gut-targeted programs for neurodegenerative diseases and neurodevelopmental disorders, today announced that company management will present at the virtual Piper Sandler 32 nd Annual Healthcare Conference taking place November 30 – December 3, 2020. The presentation will be available for registered attendees via the Piper Sandler conference site.

About Axial Therapeutics
Axial Therapeutics is a clinical-stage, biopharmaceutical company pioneering novel science focused on the interaction between the brain and the gut to mitigate the causes and symptoms of the central nervous system and other gut-derived diseases. The Company has built a pipeline of novel small molecules with lead programs to address the significant unmet patient needs associated with Parkinson’s Disease and Autism Spectrum Disorder.

Investor Contact:
Mike Beyer
SAM BROWN, INC.
312-961-2502
mikebeyer@sambrown.com